Madrigal Pharmaceuticals
MDGL
MDGL
189 hedge funds and large institutions have $3.86B invested in Madrigal Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 80 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
38% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 39
8.79% more ownership
Funds ownership: 69.17% → 77.96% (+8.8%)
31% less call options, than puts
Call options by funds: $379M | Put options by funds: $546M
Holders
189
Holding in Top 10
9
Calls
$379M
Puts
$546M
Top Buyers
| 1 | +$42.1M | |
| 2 | +$39.2M | |
| 3 | +$28.8M | |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$25.2M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$17.5M |
Top Sellers
| 1 | -$101M | |
| 2 | -$15.6M | |
| 3 | -$6.21M | |
| 4 |
Jennison Associates
New York
|
-$5.33M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$5.29M |